Skip to main content
Top
Published in: BMC Nephrology 1/2002

Open Access 01-12-2002 | Research article

Pre-dialysis clinic attendance improves quality of life among hemodialysis patients

Authors: Christine A White, Rachel M Pilkey, Miu Lam, David C Holland

Published in: BMC Nephrology | Issue 1/2002

Login to get access

Abstract

Background

Although previous research has demonstrated that referral to pre-dialysis clinics is associated with favourable objective outcomes, the benefit of a pre-dialysis clinic from the perspective of patient-perceived subjective outcomes, such as quality of life (QOL), is less well defined.

Methods

A retrospective incident cohort study was conducted to determine if pre-dialysis clinic attendance was a predictor of better QOL scores measured within the first six months of hemodialysis (HD) initiation. Inclusion criteria were HD initiation from January 1 1998 to January 1 2000, diagnosis of chronic renal failure, and completion of the QOL questionnaire within six months of HD initiation. Patients receiving HD for less than four weeks were excluded. An incident cohort of 120 dialysis patients was identified, including 74 patients who attended at least one pre-dialysis clinic and 46 patients who did not. QOL was measured using the SF 36-Item Health Survey. Independent variables included age, sex, diabetes, pre-dialysis clinic attendance and length of attendance, history of ischemic heart disease, stroke, peripheral vascular disease, heart failure, malignancy, and chronic lung disease, residual creatinine clearance at dialysis initiation, and kt/v, albumin and hemoglobin at the time of QOL assessment. Bivariate and multivariate linear regression analyses were used to identify predictors of QOL scores.

Results

Multivariate analysis suggested that pre-dialysis clinic attendance was an independent predictor of higher QOL scores in four of eight health domains (physical function, p < 0.01; emotional role limitation, p = 0.01; social function, p = 0.01; and general health, p = 0.03), even after statistical adjustment for age, sex, residual renal function, kt/v, albumin, and co-morbid disease. Pre-dialysis clinic attendance was also an independent predictor of the physical component summary score (p = 0.03).

Conclusions

We conclude that pre-dialysis clinic attendance favourably influences patient-perceived quality of life within six months of dialysis initiation.
Appendix
Available only for authorised users
Literature
1.
go back to reference NIH Consensus statement: Morbidity and mortality of dialysis. Ann Intern Med. 1994, 121: 62-70.CrossRef NIH Consensus statement: Morbidity and mortality of dialysis. Ann Intern Med. 1994, 121: 62-70.CrossRef
2.
go back to reference Binik YM, Devins GM, Barre PE, Guttmann RD, Hollomby DJ, Mandin H, et al: Live and learn: patient education delays the need to initiate renal replacement therapy in end-stage renal disease. J Nerv Ment Dis. 1993, 181: 371-376.CrossRefPubMed Binik YM, Devins GM, Barre PE, Guttmann RD, Hollomby DJ, Mandin H, et al: Live and learn: patient education delays the need to initiate renal replacement therapy in end-stage renal disease. J Nerv Ment Dis. 1993, 181: 371-376.CrossRefPubMed
3.
go back to reference Rasgon S, Schwankovsky L, James-Rogers A, Widrow L, Glick J, Butts E: An interview for employment maintenance among blue-collar workers with end-stage renal disease. Am J Kidney Dis. 1993, 22: 403-412.CrossRefPubMed Rasgon S, Schwankovsky L, James-Rogers A, Widrow L, Glick J, Butts E: An interview for employment maintenance among blue-collar workers with end-stage renal disease. Am J Kidney Dis. 1993, 22: 403-412.CrossRefPubMed
4.
go back to reference Ahlem J, Carlsson L, Schonborg C: Well-informed patients with end-stage renal disease prefer peritoneal dialysis to hemodialysis. Perit Dial Int. 1993, 13 (Suppl 2): S196-198. Ahlem J, Carlsson L, Schonborg C: Well-informed patients with end-stage renal disease prefer peritoneal dialysis to hemodialysis. Perit Dial Int. 1993, 13 (Suppl 2): S196-198.
5.
go back to reference Klang B, Bjorvell H, Clyne N: Predialysis education helps patients choose dialysis modality and increases disease-specific knowledge. J Adv Nurs. 1999, 29: 869-876. 10.1046/j.1365-2648.1999.00957.x.CrossRefPubMed Klang B, Bjorvell H, Clyne N: Predialysis education helps patients choose dialysis modality and increases disease-specific knowledge. J Adv Nurs. 1999, 29: 869-876. 10.1046/j.1365-2648.1999.00957.x.CrossRefPubMed
6.
go back to reference Ifudu O, Dawood M, Homel P, Friedman EA: Excess morbidity in patients starting uremia therapy without prior care by a nephrologist. Am J Kidney Dis. 1996, 28: 841-845.CrossRefPubMed Ifudu O, Dawood M, Homel P, Friedman EA: Excess morbidity in patients starting uremia therapy without prior care by a nephrologist. Am J Kidney Dis. 1996, 28: 841-845.CrossRefPubMed
7.
go back to reference Holland DC, Lam M: Sub-optimal dialysis initiation in a retrospective cohort of predialysis patients. Scand J Urol Nephrol. 2000, 34: 341-347. 10.1080/003655900455396.CrossRefPubMed Holland DC, Lam M: Sub-optimal dialysis initiation in a retrospective cohort of predialysis patients. Scand J Urol Nephrol. 2000, 34: 341-347. 10.1080/003655900455396.CrossRefPubMed
8.
go back to reference Sesso R, Yoshihiro MM: Time of diagnosis of chronic renal failure and assessment of quality of life in hemodialysis patients. Nephrol Dial Transplant. 1997, 12: 2111-2116. 10.1093/ndt/12.10.2111.CrossRefPubMed Sesso R, Yoshihiro MM: Time of diagnosis of chronic renal failure and assessment of quality of life in hemodialysis patients. Nephrol Dial Transplant. 1997, 12: 2111-2116. 10.1093/ndt/12.10.2111.CrossRefPubMed
9.
go back to reference Ware JE: SF-36 Health Survey manual and interpretation guide. Boston: The Health Institute, New England Medical Centre;. 1993 Ware JE: SF-36 Health Survey manual and interpretation guide. Boston: The Health Institute, New England Medical Centre;. 1993
10.
go back to reference Ware JE: The SF-36 Health Survey. In: Quality of life and pharmaco-economics in clinical trials. Edited by: Spilker B. 1996, Philadelphia: Lippincott-Raven Publishers, 337-345. 2 Ware JE: The SF-36 Health Survey. In: Quality of life and pharmaco-economics in clinical trials. Edited by: Spilker B. 1996, Philadelphia: Lippincott-Raven Publishers, 337-345. 2
11.
go back to reference Ware JE, Kosinski M, Keller SD: SF-36 physical and mental health summary scales: a user's manual. Boston: The Health Institute, New England Medical Centre;. 1994 Ware JE, Kosinski M, Keller SD: SF-36 physical and mental health summary scales: a user's manual. Boston: The Health Institute, New England Medical Centre;. 1994
12.
go back to reference Hopman WM, Towheed T, Anastassiades T, Tenenhouse A, Poliqin S, Berger C, Joseph L, Brown JP, Murray TM, Adachi J, Hanley DA, Papadimitropoulos E, and the Canadian Multicentre Osteoporosis Study research Group: Canadian normative data for the SF-36 health survey. CMAJ. 2000, 163 (3): 265-271.PubMedPubMedCentral Hopman WM, Towheed T, Anastassiades T, Tenenhouse A, Poliqin S, Berger C, Joseph L, Brown JP, Murray TM, Adachi J, Hanley DA, Papadimitropoulos E, and the Canadian Multicentre Osteoporosis Study research Group: Canadian normative data for the SF-36 health survey. CMAJ. 2000, 163 (3): 265-271.PubMedPubMedCentral
13.
go back to reference Revicki DA, Brown RE, Feeny DH, Henry D, Teehan BP, Rudnick MR, Benz RL: Health-related quality of life associated with recombinant human erythropoietin therapy for pre-dialysis chronic renal disease patients. Am J Kidney Dis. 1995, 25: 548-554.CrossRefPubMed Revicki DA, Brown RE, Feeny DH, Henry D, Teehan BP, Rudnick MR, Benz RL: Health-related quality of life associated with recombinant human erythropoietin therapy for pre-dialysis chronic renal disease patients. Am J Kidney Dis. 1995, 25: 548-554.CrossRefPubMed
14.
go back to reference Harris LE, Luft FC, Rudy DW, Tierney WM: Clinical correlates of functional status in patients with chronic renal insufficiency. Am J Kidney Dis. 1993, 21: 161-166.CrossRefPubMed Harris LE, Luft FC, Rudy DW, Tierney WM: Clinical correlates of functional status in patients with chronic renal insufficiency. Am J Kidney Dis. 1993, 21: 161-166.CrossRefPubMed
15.
go back to reference Merkus MP, Jager KJ, Dekker FW, Boeschoten EW, Stevens P, Krediet RT, and the Necosad study group: Quality of life in patients on chronic dialysis: self-assessment 3 months after the start of treatment. Am J Kidney Dis. 1997, 29: 584-592.CrossRefPubMed Merkus MP, Jager KJ, Dekker FW, Boeschoten EW, Stevens P, Krediet RT, and the Necosad study group: Quality of life in patients on chronic dialysis: self-assessment 3 months after the start of treatment. Am J Kidney Dis. 1997, 29: 584-592.CrossRefPubMed
16.
go back to reference Kutner NG, Lin LS, Fielding B, GroOgan D, Hall DW: Continued survival of older hemodialysis patients: investigations of psychosocial predictors. Am J Kidney Dis. 1994, 24: 42-49.CrossRefPubMed Kutner NG, Lin LS, Fielding B, GroOgan D, Hall DW: Continued survival of older hemodialysis patients: investigations of psychosocial predictors. Am J Kidney Dis. 1994, 24: 42-49.CrossRefPubMed
17.
go back to reference DeOreo P: Hemodialysis patient-assessed functional health status predicts continued survival, hospitalization, and dialysis-attendance compliance. Am J Kidney Dis. 1997, 30 (2): 204-212.CrossRefPubMed DeOreo P: Hemodialysis patient-assessed functional health status predicts continued survival, hospitalization, and dialysis-attendance compliance. Am J Kidney Dis. 1997, 30 (2): 204-212.CrossRefPubMed
18.
go back to reference Holland DC, Lam M: Predictors of hospitalization and death among pre-dialysis patients: a retrospective cohort study. Nephrol Dial Transplant. 2000, 15: 650-658. 10.1093/ndt/15.5.650.CrossRefPubMed Holland DC, Lam M: Predictors of hospitalization and death among pre-dialysis patients: a retrospective cohort study. Nephrol Dial Transplant. 2000, 15: 650-658. 10.1093/ndt/15.5.650.CrossRefPubMed
19.
go back to reference Julius M, Hawthorne VM, Carpentier-Alting P, Kneisley J, Wolfe RA, Port FK: Independence in activities of daily living for end-stage renal disease patients: biomedical and demographic correlates. Am J Kidney Dis. 1989, 13: 61-69.CrossRefPubMed Julius M, Hawthorne VM, Carpentier-Alting P, Kneisley J, Wolfe RA, Port FK: Independence in activities of daily living for end-stage renal disease patients: biomedical and demographic correlates. Am J Kidney Dis. 1989, 13: 61-69.CrossRefPubMed
20.
go back to reference Mendelssohn DC, Boon Toh Kua, Singer PA: Referral for dialysis in Ontario. Arch Intern Med. 1995, 155: 2473-2478. 10.1001/archinte.155.22.2473.CrossRefPubMed Mendelssohn DC, Boon Toh Kua, Singer PA: Referral for dialysis in Ontario. Arch Intern Med. 1995, 155: 2473-2478. 10.1001/archinte.155.22.2473.CrossRefPubMed
21.
go back to reference Holland DC, Lam M: Predictors of early versus late referral among a retrospective cohort of pre-dialysis patients. Dial and Transplant. 2000, 29: 526-534. Holland DC, Lam M: Predictors of early versus late referral among a retrospective cohort of pre-dialysis patients. Dial and Transplant. 2000, 29: 526-534.
Metadata
Title
Pre-dialysis clinic attendance improves quality of life among hemodialysis patients
Authors
Christine A White
Rachel M Pilkey
Miu Lam
David C Holland
Publication date
01-12-2002
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2002
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/1471-2369-3-3

Other articles of this Issue 1/2002

BMC Nephrology 1/2002 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.